Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
Losartan conferred significant renal benefits in patients with type 2 diabetes and nephropathy, and it was generally well tolerated.
Publications
1 shownFrequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 1
- Citations
- 7,351
- Institution
- Merck & Co., Inc., Rahway, NJ, USA (United States)
External Links
Identifiers
- ORCID
- 0000-0002-2961-8774
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.